SAGIMET BIOSCIENCES
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a pipeline of proprietary FASN inhibitors.
SAGIMET BIOSCIENCES
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2007-03-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.sagimet.com
Total Employee:
11+
Status:
Active
Contact:
+1 650.561.8600
Total Funding:
293.66 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Adverum Biotechnologies
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Animal Bioscience
Animal Bioscience is a pet platform.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
BridGene Biosciences
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
D2G Oncology
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Felix Biotechnology
Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Locus Biosciences
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
New Age Meats
New Age Meats is a biotechnology company that develops healthy cultivated meat grown from animal cells instead of animal slaughter.
NexImmune
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Oncoheroes Biosciences
Oncoheroes Biosciences is a biotech company.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Reservoir Neuroscience
Reservoir Neuroscience is a biopharma company that develops novel therapeutics.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Scopus BioPharma
Scopus BioPharma is a biotechnology company that focused on developing therapeutics targeting serious diseases.
Siolta Therapeutics
Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.
Somru Bioscience
Somru Bioscience is an emerging biotechnology company dedicated to developing breakthrough antibody technology for research.
SynerGene Therapeutics
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.
Trait Biosciences
Trait Biosciences is a cannabis biotechnology company harnessing research scientists.
Triana Biomedicines
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Board_member
Board_member
2021-02-01
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
George Kemble CEO @ Sagimet Biosciences
CEO
2015-10-01
Urs Greber Co-Founder @ Sagimet Biosciences
Co-Founder
Lucas Pelkmans Co-Founder @ Sagimet Biosciences
Co-Founder
2007-03-01
George Kemble Chief Scientific Officer @ Sagimet Biosciences
Chief Scientific Officer
2011-08-01
Dennis Hom CFO and Head Corporate Development @ Sagimet Biosciences
CFO and Head Corporate Development
2015-01-01
Founder
Investors List
Invus
Invus investment in Venture Round - Sagimet Biosciences
Altium Capital
Altium Capital investment in Venture Round - Sagimet Biosciences
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Sagimet Biosciences
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Sagimet Biosciences
Ascletis
Ascletis investment in Venture Round - Sagimet Biosciences
Huimei Capital
Huimei Capital investment in Venture Round - Sagimet Biosciences
PFM Health Sciences
PFM Health Sciences investment in Venture Round - Sagimet Biosciences
Kleiner Perkins
Kleiner Perkins investment in Venture Round - Sagimet Biosciences
New Enterprise Associates
New Enterprise Associates investment in Series E - Sagimet Biosciences
Qianhai Ark
Qianhai Ark investment in Series E - Sagimet Biosciences
Official Site Inspections
http://www.sagimet.com
- Host name: ec2-35-165-36-91.us-west-2.compute.amazonaws.com
- IP address: 35.165.36.91
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
Sagimet.com lookup results from whois.registrar.amazon server:
- Domain created: 28th-Mar-2019
- Domain updated: 22nd-Feb-2025
- Domain expires: 28th-Mar-2026 0 Years, 294 Days left
- Website age: 6 Years, 71 Days
- Registrar Domain ID: 2374333637_DOMAIN_COM-VRSN
- Registrar Url: http://registrar.amazon.com
- Registrar WHOIS Server: whois.registrar.amazon
- Registrar Abuse Contact Email: trustandsafety@support.aws.com
- Registrar Abuse Contact Phone: +1.2024422253
- Name server:
- NS-1419.AWSDNS-49.ORG
- NS-2014.AWSDNS-59.CO.UK
- NS-546.AWSDNS-04.NET
- NS-94.AWSDNS-11.COM
More informations about "Sagimet Biosciences"
Senior Management - Sagimet Biosciences
Dr. O’Farrell has led Sagimet’s R&D team as senior vice president of research and development since 2019 and previously served as Sagimet’s senior director of translational sciences from …See details»
Home - Sagimet Biosciences
Denifanstat in MASH. Our lead product candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), formerly known as …See details»
Board of Directors FASN Products Company - Sagimet Biosciences
Dr. Phillips has over 25 years of pharmaceutical industry experience. She joins Sagimet’s board following an 11 year tenure as corporate and senior vice president of clinical, medical, and …See details»
Corporate Governance - Sagimet Biosciences Inc
The Board of Directors of Sagimet Biosciences Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of …See details»
Sagimet Biosciences - Crunchbase Company Profile & Funding
Sagimet Biosciences has shown positive growth indicators. The company is in a good position to deliver on its growth plans, as evidenced by the imminent Phase 3 trial of its therapeutic, …See details»
Sagimet Biosciences Announces Leadership Changes - Yahoo …
SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics …See details»
Sagimet Biosciences Announces Appointment of Anne Phillips and …
SAN MATEO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid …See details»
Sagimet Biosciences - Contacts, Employees, Board Members
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases. ... Experience the new Crunchbase, powered by AI . Experience …See details»
Sagimet Biosciences Inc. (SGMT) - Yahoo Finance Canada
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that …See details»
Sagimet Biosciences Overview | SignalHire Company Profile
Sagimet Biosciences is a private company that has been in the industry for 18 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areas. …See details»
Sagimet Biosciences - Overview, News & Similar companies
Jun 10, 2024 Who is Sagimet Biosciences. Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing a portfolio of internally discovered, …See details»
Sagimet Biosciences Announces Leadership Changes
Jul 20, 2023 /EIN News/ -- SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company …See details»
Board of Directors FASN Products Company | Sagimet Biosciences
Dr. Kemble joined Sagimet Biosciences in August 2011 as its chief scientific officer and served as chief executive officer from October 2015 until October 2022, when he transitioned to the role …See details»
Sagimet Biosciences - VentureRadar
Sagimet Biosciences is a clinical-stage pharmaceutical company developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH) and various cancers. …See details»
About | Inhibitor Of FASN - Sagimet Biosciences
Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in …See details»
Sagimet Biosciences Announces Leadership Changes - Medium
SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel …See details»
Organization: Sagimet Biosciences - Cbonds.com
Sagimet Biosciences. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»
A Brief History of Sagimet Biosciences – CanvasBusinessModel.com
Dec 19, 2024 Founding and Origins of Sagimet Biosciences. Sagimet Biosciences was founded in [year] by a team of experienced scientists and entrepreneurs with a shared vision of …See details»
Sagimet Biosciences Announces Leadership Changes
SAN MATEO, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (“Sagimet”) (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics …See details»
Sagimet Biosciences Announces Leadership Changes - Nasdaq
Jul 20, 2023 --Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic pathways, today announced a series of …See details»